SPRYCEL
NDC 0003-0855, dasatinib, tablet, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-0855
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021986
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DASATINIB80 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-0855-22 | 00003085522 | 1 BOTTLE in 1 CARTON (0003-0855-22) / 30 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4764f37b-c9e6-4ede-bcc2-8a03b7c521df
Use it
Look up 0003-0855 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-0855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-0855. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.